CXSS2400061 | 注射用特立帕肽 | teriparatide | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-06-25 | | Suzhou Genemen Biotech Co Ltd | | | view |
CXSS1700023 | 注射用特立帕肽 | teriparatide | Lyophilized | Biological Products(7) | New Drug Application | 2017-11-15 | 苏州金盟生物技术有限公司 | Suzhou Genemen Biotech Co Ltd | Certificate Issued | 2019-10-16 | view |
CXSL1200038 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(15) | New Drug Application | 2012-08-16 | 苏州金盟生物技术有限公司 | Suzhou Genemen Biotech Co Ltd | Certificate Issued | 2015-01-15 | view |
CXSS2100011 | 特立帕肽注射液 | teriparatide | Injection | Biological Products(3.3) | New Drug Application | 2021-01-19 | 信立泰(苏州)药业有限公司 | Suzhou Genemen Biotech Co Ltd | In Review | 2021-01-19 | view |
CXSL2000065 | 特立帕肽注射液 | teriparatide | Injection | Biological Products(15) | New Drug Application | 2020-04-10 | 信立泰(苏州)药业有限公司 | Suzhou Genemen Biotech Co Ltd | In Review | 2020-04-09 | view |